Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
Nguyen
Q-V
QV
Descombes
E
E
D002114:Calcinosis / Q000517:prevention & control*; D002130:Calcium Phosphates / Q000097:blood; D002614:Chelating Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000517:prevention & control*; D006801:Humans; D011073:Polyamines / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects / Q000401:mortality*; D000069603:Sevelamer
D002130:Calcium Phosphates; D002614:Chelating Agents; D011073:Polyamines; C020243:calcium phosphate; D000069603:Sevelamer